Search research articles
Contact Us
Filters
Showing results (151-160 of 223) with videos related to
Page
of 23
Sort By:
Haematologica
|
April 26, 2014
The prognostic significance of early treatment response in pediatric relapsed acute myeloid leukemia: results of the international study Relapsed AML 2001/01
Ursula Creutzig, Martin Zimmermann, Michael N Dworzak, et al.
Hemasphere
|
February 20, 2020
Phospho-Profiling Linking Biology and Clinics in Pediatric Acute Myeloid Leukemia
Angela Schumich, Michaela Prchal-Murphy, Margarita Maurer-Granofszky, et al.
British Journal of Haematology
|
June 26, 2014
Clinical relevance of molecular aberrations in paediatric acute myeloid leukaemia at first relapse
Costa Bachas, Gerrit Jan Schuurhuis, Dirk Reinhardt, et al.
Blood
|
April 27, 2016
Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study
Jasmijn D E de Rooij, Riccardo Masetti, Marry M van den Heuvel-Eibrink, et al.
British Journal of Clinical Pharmacology
|
November 20, 2024
Impact of treosulfan exposure on clinical outcome after allogeneic stem cell transplantation in children: A substudy of 2 phase 2 trials
Krzysztof Kalwak, Ajay Vora, Peter Bader, et al.
Oncotarget
|
June 29, 2016
MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia
Lonneke J Verboon, Askar Obulkasim, Jasmijn D E de Rooij, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 30, 2013
Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium
C Michel Zwaan, Carmelo Rizzari, Francoise Mechinaud, et al.
BMC Pediatrics
|
February 2, 2020
Social inequalities in the participation and activity of children and adolescents with leukemia, brain tumors, and sarcomas (SUPATEEN): a protocol for a multicenter longitudinal prospective observational study
Julia Roick, Reinhard Berner, Toralf Bernig, et al.
Nature Communications
|
July 17, 2024
Selective pressures of platinum compounds shape the evolution of therapy-related myeloid neoplasms
Eline J M Bertrums, Jurrian K de Kanter, Lucca L M Derks, et al.
Blood
|
January 4, 2008
Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis
Brian V Balgobind, Pieter Van Vlierberghe, Ans M W van den Ouweland, et al.
Page
of 23
Search research articles
Search
Showing results (151-160 of 223) with videos related to
Sort By:
Page
of 23
Haematologica
|
April 26, 2014
The prognostic significance of early treatment response in pediatric relapsed acute myeloid leukemia: results of the international study Relapsed AML 2001/01
Ursula Creutzig, Martin Zimmermann, Michael N Dworzak, et al.
Hemasphere
|
February 20, 2020
Phospho-Profiling Linking Biology and Clinics in Pediatric Acute Myeloid Leukemia
Angela Schumich, Michaela Prchal-Murphy, Margarita Maurer-Granofszky, et al.
British Journal of Haematology
|
June 26, 2014
Clinical relevance of molecular aberrations in paediatric acute myeloid leukaemia at first relapse
Costa Bachas, Gerrit Jan Schuurhuis, Dirk Reinhardt, et al.
Blood
|
April 27, 2016
Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study
Jasmijn D E de Rooij, Riccardo Masetti, Marry M van den Heuvel-Eibrink, et al.
British Journal of Clinical Pharmacology
|
November 20, 2024
Impact of treosulfan exposure on clinical outcome after allogeneic stem cell transplantation in children: A substudy of 2 phase 2 trials
Krzysztof Kalwak, Ajay Vora, Peter Bader, et al.
Oncotarget
|
June 29, 2016
MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia
Lonneke J Verboon, Askar Obulkasim, Jasmijn D E de Rooij, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 30, 2013
Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium
C Michel Zwaan, Carmelo Rizzari, Francoise Mechinaud, et al.
BMC Pediatrics
|
February 2, 2020
Social inequalities in the participation and activity of children and adolescents with leukemia, brain tumors, and sarcomas (SUPATEEN): a protocol for a multicenter longitudinal prospective observational study
Julia Roick, Reinhard Berner, Toralf Bernig, et al.
Nature Communications
|
July 17, 2024
Selective pressures of platinum compounds shape the evolution of therapy-related myeloid neoplasms
Eline J M Bertrums, Jurrian K de Kanter, Lucca L M Derks, et al.
Blood
|
January 4, 2008
Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis
Brian V Balgobind, Pieter Van Vlierberghe, Ans M W van den Ouweland, et al.
Page
of 23